The Discovery Hub is where biology meets technology to redefine how new drugs are discovered. Focused on the earliest stages of the pipeline, this track explores how advances in genomics, proteomics, and computational biology are unlocking new therapeutic targets and accelerating R&D. From hypothesis generation to candidate selection, sessions will highlight how leading organisations are improving speed, accuracy, and success rates in discovery science.
What we think you'll be interested in...
BioTechX is proud to announce its accreditation by The CPD Group , a globally recognised body for quality professional development. This milestone reflects our commitment to delivering educational experiences that foster professional growth and enhance expertise across the drug safety, pharmacovigilance, and risk management community.
This accreditation underscores our dedication to providing valuable learning opportunities in drug safety and pharmacovigilance. Attendees can leverage this recognition to support their career progression and demonstrate their commitment to continuous professional improvement.
The Interactive Poster Session at BioTechX is a dynamic showcase of the latest research, clinical innovation, and emerging developments in biotech. Open to all attendees, this session offers an exciting opportunity to explore cutting-edge work from leading clinicians, researchers, and industry experts in a collaborative, engaging environment.
Why This Matters for Innovators
While the Poster Session is open to all attendees, it offers particular value for healthcare professionals by providing practical clinical insights that are directly relevant to patient care. You will benefit from real-world learning shared by frontline delivery teams who are implementing advanced therapies, and they will gain exposure to emerging techniques, trial outcomes, and new clinical evidence. This session also provides a unique opportunity to see how advanced therapies are translating into real-world practice, helping clinicians stay at the forefront of innovation and patient treatment pathways.
Value for Innovators
Innovative professionals attending the Poster Session will gain clinically relevant insights that support professional development, with exposure to innovations across the therapy pathway from trial design to patient delivery. They will also have the opportunity to benchmark practice against leading institutions and access research and findings before wider publication.
Networking & Collaboration
The Poster Session is not just about learning—it's also about connecting. You’ll be able to meet researchers, discuss research directly, and build relationships with senior clinical leaders and industry specialists, creating valuable collaboration and referral opportunities.
Submit a Poster or Just Attend
Whether you want to present your work or simply engage with leading research, the Poster Session welcomes you. You can submit a poster to showcase your findings, clinical case studies, or innovation projects, or attend as a delegate to learn, discuss, and connect with experts. The session also provides the opportunity to contribute to the conversation through questions, insights, and collaboration.
Explore how AI is reshaping drug discovery from target identification through to optimisation, with a focus on multimodal data, predictive modelling, and model-informed development strategies.
Uncover how computational biology, multi-omics, and simulation are driving deeper biological insight and enabling more precise, data-led therapeutic development.
Learn how AI is advancing imaging across both research and clinical settings, enabling improved diagnostics, image analysis, and data-driven endpoints.
See how LLMs and agentic AI are being embedded across R&D to extract knowledge, automate workflows, and enhance scientific decision-making at scale.
Dive into how computational chemistry and data-driven design are accelerating molecular discovery, from building scalable compound libraries to advancing hit and lead optimisation.
Discover how quantum computing and next-generation AI approaches are opening new frontiers in drug discovery and solving previously intractable problems.
Explore cutting-edge approaches in genomics, proteomics, and multi-omics to uncover and validate novel drug targets. Learn how leading teams are improving confidence in early-stage discovery decisions.
Discover how AI, automation, and high-throughput technologies are reducing timelines from hypothesis to candidate selection. Collaborate with biotech and pharma innovators to overcome bottlenecks in early discovery.